HIGHLIGHTS
- who: Sung-Ting Chuang et al. from the Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA have published the research: Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of /2022/
- what: The authors show that concentration dependently inhibits this PPI for the spike of the original strain as well as for those of variants of concern such as the D614G mutant and delta (B.1.617.2) with IC50 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.